30 September 2024
XEROS TECHNOLOGY GROUP
PLC
("Xeros" or the
"Company" or the "Group")
AIM: XSG
INTERIM RESULTS 2024
Commercial momentum
building
Xeros, the creator of technologies that reduce
the impact of clothing on the planet, announces its unaudited
interim results for the six months ended 30 June 2024.
Commercial
highlights
Care
|
·
|
Working with three new global domestic, and one
new commercial, laundry tier 1 OEMs to demonstrate the benefits of
Xeros technology on their platforms
|
·
|
Positive feedback on Xeros enabled 9kg domestic
washing machine from IFB Industries Limited's ("IFB") consumer
trials; full market launch now expected to take place in 2025 as
announced earlier in September
|
Finish
|
·
|
A range of Xeros-enabled denim finishing
machines was launched successfully by KRM Tekstil/Yilmak
Makina ("Yilmak") at ITM 2024, a leading garment finishing
show
|
·
|
Yilmak now working through sales leads with
expectation of machines being in full production and revenue
generating in 2024
|
·
|
In parallel, Xeros working with market-leading
fashion brands to demonstrate the specific benefits of its
technology on their garments and finishes to support Yilmak's
market launch
|
Filtration
|
·
|
Signed significant new licensing agreement and
strategic partnership with world-leading manufacturer, Donlim Group
("Donlim"), owner of the Morphy Richards brand and ideally placed
to support the commercialisation of the Group's external,
micro-fibre filtration solution for washing machines
|
·
|
Showcase of Xeros technology and Donlim
partnership at IFA Berlin, Europe's largest consumer electronics
show, in September 2024
|
·
|
·
Micro-fibre filtration industry still awaits clarification
from the French Government on standards and efficacies for its 2025
legislation and we still expect that legislation will be
implemented in major global markets in the coming years
|
Key
financials
·
|
Revenue of £79k (H1 23: £113k)
|
·
|
Lower administrative expenses at £2.6m (H1 23:
£2.8m)
|
·
|
Net cash outflow from operations of £2.6m (H1
23: £2.9m) with cash at 31 August 2024 of £4.0m
|
Outlook
·
|
Revenues from Yilmak, the Group's denim finishing
partner, expected to come online in H2 FY24
|
·
|
Viability of the successful commercialisation of Xeros
technologies is as strong as ever, as demonstrated by the
increasing quality of the Group's existing licensing agreements and
quality of interest from a number of major global laundry OEMs
|
·
|
The Group's current financing sufficient to
support the business through to month-on-month cashflow breakeven,
which is expected during FY25
|
·
|
Xeros remains well placed to execute on the
partnerships in hand and to win significant new commercial
contracts with current people and cost base
|
Neil Austin,
CEO said:
"The drivers for clean-tech solutions are
gaining momentum and we are on track with the globalisation of our
technologies. Our recent agreement with Donlim, world-renowned for
delivering domestic appliances on a global scale, clearly
demonstrates the potential for our technology and the quality of
partner the business is now able to attract. In addition to the
commercialisation of our technologies through existing licensees,
we are in active discussion with some of the world's best known
brand manufacturers in laundry care. This is an exciting time for
Xeros, and we remain committed to delivering value to all
stakeholders."
Enquiries:
Xeros Technology Group
plc
Neil
Austin, Chief Executive Officer
Alex
Tristram, Finance Director
|
Tel: 0114
269 9656
|
Cavendish Capital Markets
Limited (Nominated Adviser and Broker)
Julian
Blunt/Teddy Whiley, Corporate Finance
Andrew
Burdis/Sunila de Silva, ECM
|
Tel: 020
7220 0500
|
Rawlings Financial PR
Limited
Cat
Valentine
|
Tel: 07715
769078
cat@rfpr.co.uk
|
About Xeros
Xeros Technology plc has developed
patented and proven, industry-leading technologies which reduce the
environmental impact of how industries make and care for
clothes.
The traditional wet processing
methods used in industrial and domestic laundry and garment
manufacturing consume billions of litres of fresh water and large
amounts of energy and chemicals, as well as damaging and weakening
clothing fibres and creating rising levels of environmental
pollution. It is estimated that washing machines contribute 35% of
the 171 trillion microplastic particles in the ocean.
A range of actors, including
consumers, the media NGOs and regulators are exerting pressure on
these industries, with legislative action beginning to be
taken.
Xeros' three main technologies,
Filtration, Finish, and Care, facilitate garment manufacturers,
industrial laundries, domestic washing machine manufacturers and
consumers, to reduce their environmental impact, whilst also
significantly improving efficiency in the process.
Xeros' model is to generate revenue
from licensing its technologies, generating royalties and the sale
of consumables. Currently there are eight agreements in place. The
addressable markets in Filtration, Finish and Care are estimated to
be valued at £350m p.a., £132m p.a. and £3bn p.a.
respectively.
CEO STATEMENT
I am pleased to report on the progress the Group has
made in the six months to 30 June 2024 and to provide an update on
the Group's commercial partners and opportunities.
The societal and commercial pressure, being faced by
companies across the globe, to deliver effective environmental
solutions is a reality. Consumer awareness about the impact of
their choices continues to grow, with the negative impact of
microplastics on the world becoming more apparent every day. Xeros
has the technologies to provide impactful solutions to some of the
biggest companies in the world and we continue to work to do
so.
Earlier this month, Xeros signed a new licensing
agreement with Donlim to manufacture the Xeros' XF3 technology
under license. Donlim, which is one of the world's leading domestic
appliance manufacturers and owner of the Morphy Richards brand, is
ideally placed to support the commercialisation of the Group's
external filtration device, XF3.
While the recently announced delay to the launch
timetable of our Indian partner, IFB Industries Limited ("IFB"),
not related to the Xeros technology, was disappointing, the
opportunities we have, to commercialise our technologies at scale
through multiple global partners, are significant. This is
demonstrated by the interest of a number of major global players in
the laundry and garment processing industries, as well as by our
existing partner agreements. Their engagement gives me comfort that
the technology benefits of our technologies are clear.
The Group has clear commercial objectives, in both
the short and medium-term, and remains well placed to execute on
the partnerships in hand and to win new, significant commercial
contracts.
Summary of the
results
The Group continued to focus on cost control during
the Period, further reducing its administrative costs and taking
measures which it expects to positively impact administrative
expenses in future years. 2024 SG&A is expected to be around
60% of the 2022 level, when I joined the Group. Revenue remained
static against the prior half year, with revenues from Yilmak, the
Group's denim finishing partner, expected to come online in H2
FY24.
The Group's ongoing cash requirement was impacted by
the delays in revenue from IFB. However, we continue to expect
revenues from a number of partners in the coming months, which will
support our cash position. We continue to monitor our cash
requirement closely and believe that our existing resources will
enable us to reach break-even.
Business
update
Care
Xeros' Laundry Care System uses reusable polymer
spheres, known as XOrbs, to wash and care for textiles, and is
scalable from domestic wash to heavy industrial and commercial use.
Using the Xeros Laundry Care System drastically reduces the amount
of water, energy and chemistry required by the laundry process, as
well as increasing the life of the garments washed by up to
100%.
Xeros reported, earlier in 2024, that the technology
transfer process with its Indian licensee, IFB, was complete and
that IFB was undergoing field trials ahead of a 2024 mass market
launch. The trials generated positive consumer feedback, but
IFB has initiated a further change to the specification of the 9kg
machine, unrelated to Xeros technology, which has pushed back its
expected mass market launch into 2025. This situation has been
compounded by the recent announcement of a change in leadership in
the Home Appliances Division of IFB. While the delay to mass market
launch is clearly disappointing, the progress made by IFB, combined
with the feedback received as part of this process, provide
compelling evidence of Xeros' technology in a domestic laundry
setting.
Xeros is in the process of demonstrating the
benefits of its Care technology to a number of global, tier 1
potential partners on both domestic and commercial platforms and
expects to be able to communicate the outcome of these discussions
in the coming months.
Filtration
The awareness from consumers and from brands of
the impact of microfibres, including microplastics, continues to
rise, in the face of near-constant environmental
studies.
Domestic laundry is the second largest
contributor, with up to 700,000 fibres released in every wash. The
Group's microfibre pollution filter can be fitted as an accessory
to washing machines at home (XF3) or integrated during manufacture
(XF1), removing 99% of microfibres from laundry wastewater for safe
disposal.
The Group's licensing and strategic partnership
with the Donlim, signed after the Period end, provides Xeros with a
strong and heavyweight route to market for the external device, the
XF3. It also added a further licensee for the internal XF1,
increasing the Group's geographic supply coverage for potential
global laundry partners. Donlim is a world leader in the
manufacture of electrical appliances, with three manufacturing
sites and over $2bn of revenue, and ideally placed to support Xeros
developing a new market for microfibre filtration
solutions.
The Group showcased its external filtration
technology together with Donlim, at IFA Berlin, Europe's largest
consumer electronics fair, in September 2024. The industry
consensus at IFA was that the market for washing machine filtration
is coming in the short term, even without legislation, but that it
remains in development.
The awareness of the widening impacts of
microplastics extends beyond consumers and the media into global
organisations and governments. The filtration industry is still
awaiting clarification from the French Government as to the
standards and efficacies required by its 2025-dated legislation.
Frustratingly, this has delayed previously expected demand for
filtration products, but the issue remains on the agenda across the
globe, with progress being made at both an EU and State level in
the US, including California.
Finish
The finishing process undergone by denim garments is
a process which uses large amounts of water and chemistry and
produces huge volumes of effluent, often contaminated with
chemicals. Xeros' Garment Finishing System allows manufacturers to
achieve equivalent finishes on their garments, while reducing the
energy, chemistry, and water needs of the process by up to 50%.
Yilmak launched a Xeros enabled range of denim
finishing machines at ITM, a leading garment finishing trade show,
in July 2024. It is working through the initial sales leads,
with the expectation of machines being in full production within
the current calendar year. The company is a tier 1 OEM within the
global garment finishing market and represents a meaningful revenue
opportunity for the Group. Revenue generation for Xeros from
this licensing agreement remains on track to commence in the
current financial year.
Strategy
The industries in which the Xeros technologies could
have impact include the $2.5 trillion fashion industry and the $55
billion domestic laundry market, which are some of the largest
markets in the world. Xeros considers that its addressable markets
within these industries total £350 million, £392 million, and £2.3
billion for Filtration, Finish, and Care respectively.
The Group's strength lies in its IP portfolio and the
deep technology transfer-knowhow with the business. The Group's
strategy remains to license this portfolio of proprietary solutions
to multiple scale industries, all of which are relevant for the
Group's core technologies. It is through the commercialization of
the Group's technology, through those best placed to do so, that
the Group will generate revenue and return. The Group has partners
around the globe with the market position and the knowhow to
maximise the impact of its technology and is in active commercial
processes with others with the potential to do the same.
A number of these partners have successfully deployed
Xeros-enabled products into demanding markets and have shown the
benefits in a real-world environment. The Group's strategy over the
coming months is to develop its partnerships further to allow the
Xeros technologies to be adopted on the widest possible scale.
Drivers for
growth
The industries in which the Xeros technologies are
relevant have traditionally been slow moving and slow to innovate.
The conflict of this inertia with the drive from consumers,
industry bodies, and governments for environmental progress means
that the opportunities for our technologies remain significant. The
underlying demand for our products was highlighted at Europe's
largest consumer electronics show, IFA, in Berlin, at which Xeros
exhibited. The resounding message from [laundry] manufacturers and
OEMS at the event was to use less and prolonging the life of
garments. However, the technical innovations to support a step
change was lacking. Against this background, we [are approaching
and engaging / can approach and engage] with some of the largest
companies in the world - with genuine innovation that the industry
is ready for.
The same is true of the fashion industry, which
continues to come under the microscope for the impact that its
production has on the world. Fashion retailers, and the garment
producers that serve them, are grappling with the need to keep
costs down in an increasingly competitive market, whilst reducing
their carbon footprint and the waste they create. Some
forward-thinking producers are taking the lead and will be at the
forefront of the coming change to the industry, with a focus on
sustainability, quality, and supply chain transparency. We are
working with a number of fashion brands to demonstrate the impact
of our garment finishing technology and are confident that proving
out the benefits to them, both from a cost and sustainability point
of view, is key in establishing the early market for Xeros enable
garment finishing machines.
The market for microplastic filtration continues to
develop, albeit at a slower pace than we previously expected, for
the reasons mentioned above. It is, however, clear from our
interactions with the industry that legislation will eventually
compel filtration in washing machines, but this will take time. We
believe that consumers will take the first steps in tackling the
menace of microplastics, installing external filters to their
machines. This view is supported by the consumer insight studies
that we have conducted and the discussions we have held with other
stakeholders.
Sales
pipeline
We remain focused on mass-market adoption of Xeros'
key technologies, and the licences we have in hand. The
high-quality, active discussions and processes we are currently
having, with global, tier 1 potential partners, provide confidence
that we are moving in the right direction.
The Company is currently working through a number of
significant opportunities on both its Care and Filtration
technologies. We are in active processes with three tier 1 OEMs in
relation to our domestic care technology and with a further tier 1
OEM in relation to commercial care technology. The Group's recent
licensing agreement with Donlim provides a short-term route to
market for the XF3 filter, as well as having the potential for
longer-term strategic alignment.
The full market launch of our denim finishing
technology by Yilmak, alongside the existing market development
done by Ramsons, provides a meaningful revenue opportunity, as well
as allowing us to make connections with global fashion brands who
see the positive consumer perception impact of our technology and
the manufacturers who can ensure the supply of sustainable garments
into the market. IFB remain committed to the mass market launch of
a Xeros enabled domestic machine and we expect this to take place
in 2025.
Outlook
We remain encouraged by the significant pipeline of
opportunities in play for Xeros, and by the breadth of interest in
all the Group's core technologies. The outcome of our current round
of commercial discussions and processes will be crucial for the
future of the Group, and we look forward to providing further
updates in due course.
Neil
Austin
CEO
FINANCIAL REVIEW
Group revenue was generated as
follows:
|
Unaudited
6 months to
|
Unaudited
6 months
to
|
12 months
ended
|
|
30 June
|
30 June
|
31
December
|
|
2024
|
2023
|
2023
|
|
£'000
|
£'000
|
£'000
|
Licensing income
|
23
|
11
|
82
|
Service income
|
43
|
44
|
138
|
Sale of goods
|
10
|
57
|
77
|
Other revenue
|
3
|
1
|
-
|
|
|
|
|
|
|
|
|
Total revenue
|
79
|
113
|
297
|
|
|
|
|
|
|
|
|
The Group financial results for the six months
ended 30 June 2024 reflect further consolidation of the Group's
cost base, as we work towards a step change in revenue driven by
the mass-market launches of Xeros technologies. The Group recorded
a 6.6% decrease in operating loss to £2.5m (H1 2023:
£2.7m.)
Licensing income represents royalties from
licence partners for the sale of XDrum machines and revenue to
Xeros for the sale of XOrbs, which has remained broadly static
against the H1 2023. Service income and machine sales represents
payments from existing Xeros customers in the UK and Europe. The
Group expects that future revenues will be comprised mostly of
licensing revenue and revenue from the sale of goods, as it
supplies XOrbs to customers.
Gross profit for the six months ended 30 June
2024 remained static at £0.1m (2023: £0.1m).
Administrative expenses decreased by 7.1% to
£2.6m (H1 2023: £2.8m), driven by further close management of the
Group's cost base. Headcount fell in comparison with the previous
year, with 24 employees as of 31 August 2024 (2023: 32). As a
consequence, the Group's adjusted EBIDTA fell by 8.2% to £2.4m (H1
2023: £2.6m).
Adjusted EBITDA is considered one of the key
financial performance measures of the Group as it reflects the true
nature of our continuing trading activities. Adjusted EBITDA is
defined as the loss on ordinary activities before interest, tax,
share-based payment expense, non-operating exceptional costs,
depreciation and amortisation.
The Group decreased its operating loss to £2.5m
(H1 2023: £2.7m), a decrease of 6.6%. The loss per share was 1.69p
(2023: loss 1.81p).
Net cash outflow from operations decreased
8.5% to £2.6m (H1 2023: £2.9m), reflecting the timing of some of
the Group's significant invoices. The Group had existing cash
resources (including cash on deposit) as at 30 June 2024 of £4.7m
(2023: £3.5m) and remains debt free. Group cash as at 31 August
2023 was £4.0m.
Overall cash utilisation remains in line with
the Board's expectations at below £0.5m per month. The directors
expect cash utilisation to be lower in the second half of 2024 and
2025, and that these lower levels will continue as the Group moves
into full commercialisation with licence partners. The Board
considers the Group's current cash reserves to be sufficient to
support the Group through to month-on-month cashflow breakeven,
expected in 2025.
Alex
Tristram
Director of
Finance
Consolidated
statement of profit or loss and other comprehensive
income
For the six months ended 30 June
2024
|
|
Unaudited
|
Unaudited
|
|
|
|
Six months
|
Six months
|
12 months
|
|
|
ended
|
ended
|
ended
|
|
|
30 June
|
30 June
|
31
December
|
|
|
2024
|
2023
|
2023
|
|
Note
|
£'000
|
£'000
|
£'000
|
|
|
|
|
|
Revenue
|
|
79
|
113
|
297
|
Cost of sales
|
|
(14)
|
(28)
|
(52)
|
|
|
_______
|
_______
|
_______
|
Gross
profit
|
|
65
|
85
|
245
|
|
|
|
|
|
Administrative expenses
|
|
(2,593)
|
(2,791)
|
(4,982)
|
|
|
|
|
|
Adjusted
EBITDA*
|
|
(2,425)
|
(2,642)
|
(4,606)
|
Share based payment expense
|
|
(23)
|
9
|
20
|
Depreciation of tangible fixed
assets
|
|
(80)
|
(73)
|
(151)
|
|
|
|
|
|
Operating
loss
|
|
(2,528)
|
(2,706)
|
(4,737)
|
Finance income
|
|
-
|
-
|
1
|
Finance expense
|
|
(18)
|
(19)
|
(39)
|
|
|
_______
|
_______
|
_______
|
Loss before
taxation
|
|
(2,546)
|
(2,725)
|
(4,775)
|
Taxation
|
3
|
-
|
(1)
|
520
|
|
|
_______
|
_______
|
_______
|
Loss after
tax
|
|
(2,546)
|
(2,726)
|
(4,255)
|
|
|
_______
|
_______
|
_______
|
Other
comprehensive loss
|
|
|
|
|
Items that are or maybe reclassified to profit
or loss:
|
|
|
|
|
Foreign currency translation differences -
foreign operations
|
|
-
|
9
|
2,209
|
|
|
___
____
|
__
_____
|
_______
|
Total
comprehensive expense for the period
|
|
(2,546)
|
(2,717)
|
(2,046)
|
|
|
___ ____
|
____ _
__
|
_______
|
Loss per
ordinary share
|
|
|
|
|
Basic and diluted on loss from continuing
operations
|
6
|
(1.69)p
|
(1.81)p
|
(2.82)p
|
|
|
_______
|
_______
|
_______
|
*Adjusted EBITDA comprises loss on
ordinary activities before interest, tax, share-based payment
expense, depreciation and amortisation.
Consolidated
statement of changes in equity
For the six months ended 30 June
2024
|
Share
capital
|
Share
premium
|
Deferred
share
capital
|
Merger
reserve
|
Warrant
reserve
|
Foreign
currency
translation
reserve
|
Retained
earnings
deficit
|
Total
|
|
£'000
|
£'000
|
£'000
|
£'000
|
£'000
|
£'000
|
£'000
|
£'000
|
|
|
|
|
|
|
|
|
|
At 1
January 2023 (restated)
|
151
|
125,766
|
3,544
|
15,443
|
947
|
(2,209)
|
(137,773)
|
5,869
|
Loss for
the year
|
-
|
-
|
-
|
-
|
-
|
-
|
(4,255)
|
(4,255)
|
Other
comprehensive expense
|
-
|
-
|
-
|
-
|
-
|
10
|
-
|
10
|
Other
comprehensive expense: Reclassification of historical foreign
exchange on the closure of overseas subsidiaries
|
-
|
-
|
-
|
-
|
-
|
2,199
|
(2,199)
|
-
|
Loss and
total comprehensive expense for the period
|
-
|
-
|
-
|
-
|
-
|
2,209
|
(6,454)
|
(4,245)
|
Transactions with Owners recorded directly in
equity:
|
|
|
|
|
|
|
|
|
Share based
payment expense
|
-
|
-
|
-
|
-
|
-
|
-
|
(20)
|
(20)
|
Total
contributions by and distributions to owners
|
-
|
-
|
-
|
-
|
-
|
-
|
(20)
|
(20)
|
At 31 December
2023
|
151
|
125,766
|
3,544
|
15,443
|
947
|
-
|
(144,247)
|
1,604
|
|
|
|
|
|
|
|
|
|
At 1 January 2023
(restated)
|
151
|
125,766
|
3,544
|
15,443
|
947
|
(2,209)
|
(137,773)
|
5,869
|
Loss for
the period
|
-
|
-
|
-
|
-
|
-
|
-
|
(2,726)
|
(2,726)
|
Other
comprehensive expense
|
-
|
-
|
-
|
-
|
-
|
9
|
-
|
9
|
Loss and
total comprehensive expense for the period
|
-
|
-
|
-
|
-
|
|
9
|
(2,726)
|
(2,717)
|
Transactions with Owners recorded directly in
equity:
|
|
|
|
|
-
|
|
|
|
Share based
payment expense
|
-
|
-
|
-
|
-
|
-
|
-
|
(9)
|
(9)
|
Total
contributions by and distributions to owners
|
-
|
-
|
-
|
-
|
-
|
-
|
(9)
|
(9)
|
At 30 June
2023
|
151
|
125,766
|
3,544
|
15,443
|
947
|
(2,200)
|
(140,508)
|
3,143
|
|
|
|
|
|
|
|
|
|
Balance at 1 January
2024
|
151
|
125,766
|
3,544
|
15,443
|
947
|
-
|
(144,247)
|
1,604
|
Loss for
the period
|
-
|
-
|
-
|
-
|
-
|
-
|
(2,545)
|
(2,545)
|
Other
comprehensive expense
|
-
|
-
|
-
|
-
|
-
|
(1)
|
-
|
(1)
|
Loss and
total comprehensive income for the period
|
-
|
-
|
-
|
-
|
-
|
(1)
|
(2,545)
|
(2,546)
|
Transactions with Owners recorded directly in
equity:
|
|
|
|
|
|
|
|
|
Issue of
shares following placing and open offer
|
370
|
5,970
|
-
|
-
|
-
|
-
|
-
|
6,340
|
Cost of
share issues
|
-
|
(517)
|
-
|
-
|
-
|
-
|
-
|
(517)
|
Share based
payment expense
|
-
|
-
|
-
|
-
|
-
|
-
|
23
|
23
|
Total
contributions by and distributions to owners
|
370
|
5,453
|
-
|
-
|
-
|
-
|
23
|
5,846
|
At 30 June
2024
|
521
|
131,219
|
3,544
|
15,443
|
947
|
(1)
|
(146,769)
|
4,904
|
Consolidated
statement of financial position
As at 30 June 2024
|
Unaudited
|
Unaudited
|
|
|
30 June
|
30 June
|
31
December
|
|
2024
|
2023
|
2023
|
|
£'000
|
£'000
|
£'000
|
Assets
|
|
|
|
Non-current
assets
|
|
|
|
Property, plant and equipment
|
107
|
108
|
129
|
Right of use assets
|
718
|
826
|
772
|
Trade and other receivables
|
-
|
-
|
-
|
|
825
|
934
|
901
|
Current
assets
|
|
|
|
Inventories
|
160
|
162
|
159
|
Trade and other receivables
|
650
|
262
|
352
|
Cash on deposit
|
4
|
4
|
4
|
Cash and cash equivalents
|
4,711
|
3,494
|
1,595
|
|
5,525
|
3,922
|
2,110
|
|
|
|
|
Total
assets
|
6,350
|
4,856
|
3,011
|
|
|
|
|
Liabilities
|
|
|
|
Non-current
liabilities
|
|
|
|
Right of use liabilities
|
(683)
|
(689)
|
(727)
|
Deferred tax
|
(38)
|
(38)
|
(38)
|
|
(721)
|
(727)
|
(765)
|
|
|
|
|
Current
liabilities
|
|
|
|
Trade and other payables
|
(725)
|
(986)
|
(642)
|
|
(725)
|
(986)
|
(642)
|
|
|
|
|
Total
liabilities
|
(1,446)
|
(1,713)
|
(1,407)
|
|
|
|
|
Net
assets
|
4,904
|
3,143
|
1,604
|
Equity
|
|
|
|
Share capital
|
521
|
151
|
151
|
Share premium
|
131,219
|
127,660
|
125,766
|
Deferred share capital
|
3,544
|
3,544
|
3,544
|
Merger reserve
|
15,443
|
15,443
|
15,443
|
Foreign currency translation reserve
|
(1)
|
(2,200)
|
-
|
Accumulated losses
|
(146,769)
|
(140,508)
|
(144,247)
|
Warrant reserve
|
947
|
(947)
|
947
|
Total
equity
|
4,904
|
3,143
|
1,604
|
Consolidated
statement of cash flows
For the six months ended 30 June
2024
|
Unaudited
|
Unaudited
|
|
|
6 months to
|
6 months
to
|
12 months
to
|
|
30 June
|
30 June
|
31
December
|
|
2024
|
2023
|
2023
|
|
£'000
|
£'000
|
£'000
|
Operating
activities
|
|
|
|
Loss before tax
|
(2,546)
|
(2,725)
|
(4,775)
|
Adjustment for non-cash items:
|
|
|
|
Depreciation of property, plant and
equipment
|
80
|
73
|
151
|
Share based (credit)/expense
|
23
|
(9)
|
(20)
|
(Increase)/decrease in inventories
|
(1)
|
2
|
5
|
(Increase)/decrease in trade and other
receivables
|
(298)
|
130
|
40
|
Increase/(decrease) in trade and other
payables
|
80
|
(379)
|
(615)
|
Finance income
|
-
|
-
|
(2)
|
Finance expense
|
19
|
19
|
39
|
Cash used in
operations
|
(2,643)
|
(2,889)
|
(5,177)
|
Tax (payments)/receipts
|
-
|
(1)
|
520
|
Net cash
outflow used in operations
|
(2,643)
|
(2,890)
|
(4,657)
|
|
|
|
|
Investing
activities
|
|
|
|
Finance income
|
-
|
-
|
1
|
Finance expense
|
(19)
|
(19)
|
(39)
|
Cash withdrawn from/(placed on)
deposit
|
-
|
-
|
-
|
Purchases of property, plant and
equipment
|
(4)
|
(38)
|
(79)
|
Net cash
inflow/(outflow) from investing activities
|
(23)
|
(57)
|
(117)
|
|
|
|
|
Financing
activities
|
|
|
|
Proceeds from issue of share capital, net of
costs
|
5,824
|
-
|
-
|
Payment of lease liabilities
|
(41)
|
(31)
|
(105)
|
Net cash
(outflow)/inflow from financing activities
|
5,783
|
(31)
|
(105)
|
|
|
|
|
Increase/(decrease) in cash and cash
equivalents
|
3,117
|
(2,978)
|
(4,879)
|
Cash and cash equivalents at start of
year
|
1,595
|
6,465
|
6,469
|
Effect of exchange rate fluctuations on cash
held
|
(1)
|
7
|
5
|
Cash and cash
equivalents at end of the period
|
4,711
|
3,494
|
1,595
|
Notes to the
interim financial information
for the six months ended 30 June
2024
1. General
information
The principal activity of Xeros Technology
Group plc ("the Company") and its subsidiary companies (together
"Xeros" or the "Group") is the development and licensing of
platform technologies which transform the sustainability and
economics of clothing and fabrics during their manufacture and over
their lifetime of use.
Xeros Technology Group plc is domiciled in the
UK and incorporated in England and Wales (registered number
8684474), and its registered office address is Unit 2 Evolution,
Advanced Manufacturing Park, Whittle Way, Catcliffe, Rotherham, S60
5BL. The Company's principal activity is that of a holding
company.
The interim financial information was approved
for issue on 30 September 2024.
2. Basis of
preparation
The interim financial information has been
prepared under the historical cost convention and in accordance
with the recognition and measurement principles of UK-adopted
International Accounting Standards ("IFRSs").
The interim financial information has been
prepared on a going concern basis and is presented in Sterling to
the nearest £'000.
The accounting policies used in the interim
financial information are consistent with those used in the prior
year.
The following adopted IFRSs have been issued
but have not been applied by the Group in this financial
information. Their adoption is not expected to have a material
effect on the financial information unless otherwise
indicated:
·
|
Amendments to IAS 21, The Effects of Changes in Foreign Exchange
Rates, effective 1 January 2025
|
·
|
Amendments to IAS 7, Statements of Cashflows and IFRS 7,
Financial Instruments,
Disclosures, effective 1 January 2024
|
·
|
Amendments to IAS 1, Presentation of Financial Statements,
effective 1 January 2024
|
·
|
Amendments to IFRS 16, Leases, effective 1 January
2024
|
Further IFRS standards or interpretations may
be issued that could apply to the Group's financial statements for
the year ending 31 December 2024. If any such amendments, new
standards or interpretations are issued then these may require the
financial information provided in this report to be changed. The
Group will continue to review its accounting policies in light of
emerging industry consensus on the practical application of
IFRS.
The preparation of financial information in
conformity with the recognition and measurement requirements of
IFRS requires management to make estimates and assumptions that
affect the reported amounts of assets and liabilities at the date
of the financial statements and the reported amounts of revenues
and expenses during the reporting period. Although these estimates
are based on management's best knowledge of the amount, event or
actions, actual events ultimately may differ from those
estimates.
The interim financial information does not
include all financial risk management information and disclosures
required in annual financial statements. There have been no
significant changes in any risk or risk management policies since
31 December 2023. The principal risks and uncertainties are
materially unchanged and are as disclosed in the Annual Report for
the year ended 31 December 2023.
The interim financial information for the six
months ended 30 June 2024 and for the six months ended 30 June 2023
does not constitute statutory financial statements as defined in
Section 434 of the Companies Act 2006 and is neither reviewed nor
audited. The comparative figures for the year ended 31 December
2023 are not the Group's consolidated statutory accounts for that
financial year. Those accounts have been reported on by the
Group's auditor and delivered to the Registrar of Companies.
The report of the auditor was (i) unmodified, (ii) did not contain
a statement under Sections 498(2) or 498(3) of the Companies Act
2006. The report did contain an emphasis of matter paragraph in
relation to a material uncertainty in respect of the going concern
status of the Group as at 31 December 2023. The circumstances that
gave rise to this emphasis of matter paragraph are unchanged as at
the date of this report.
The half year condensed consolidated financial
statements do not include all of the information and disclosures
required for full annual financial statements and should be read in
conjunction with the group's annual financial statements as at 31
December 2023, which have been prepared in accordance with UK
adopted International Accounting Standards (IFRS).
IAS 34 'Interim financial reporting' is not
applicable to these half-year condensed consolidated financial
statements and has therefore not been applied.
3.
Taxation
|
Unaudited
|
Unaudited
|
|
|
6 months to
|
6 months
to
|
Year ended
|
|
30 June
|
30 June
|
31
December
|
|
2024
|
2023
|
2023
|
|
£'000
|
£'000
|
£'000
|
Current
tax:
|
|
|
|
UK tax credits received in respect of prior
periods
|
-
|
-
|
(521)
|
Foreign taxes paid
|
-
|
1
|
1
|
Total tax charge/(credit)
|
-
|
1
|
(520)
|
The Group accounts for Research and Development
tax credits where there is certainty regarding HMRC approval. There
is no certainty regarding the claim for the year ended 31 December
2023 and as such no relevant credit or asset is
recognised.
4. Trade and
other receivables
|
Unaudited
|
Unaudited
|
|
|
30 June
|
30 June
|
31
December
|
|
2024
|
2023
|
2023
|
|
£'00
|
£'000
|
£'000
|
Due within 12
months:
|
|
|
|
Trade receivables
|
13
|
4
|
10
|
Other receivables
|
261
|
40
|
11
|
Prepayments and accrued income
|
376
|
218
|
331
|
|
650
|
262
|
352
|
Due after more
than 12 months
|
|
|
|
Other receivables
|
-
|
-
|
-
|
There is no material difference between the
lease receivable amounts as in other receivables noted above and
the minimum lease payments or gross investments in the lease as
defined by IFRS 16.
The minimum lease payment is receivables as
follows:
|
Unaudited
|
Unaudited
|
|
|
30 June
|
30 June
|
31
December
|
|
2024
|
2023
|
2023
|
|
£'000
|
£'000
|
£'000
|
Not later than one year
|
2
|
17
|
7
|
Later than one year not later than five
years
|
-
|
-
|
-
|
|
2
|
17
|
7
|
Contractual payment terms with the Group's
customers are typically 30 to 60 days. The Directors believe that
the carrying value of trade and other receivables represents their
fair value. In determining the recoverability of trade receivables
the Directors consider and change in the credit quality of the
receivable from the date credit was granted up to the reporting
date.
5. Trade and
other payables
|
Unaudited
|
Unaudited
|
|
|
30 June
|
30 June
|
31
December
|
|
2024
|
2023
|
2023
|
|
£'000
|
£'000
|
£'000
|
Trade payables
|
383
|
211
|
206
|
Taxes and social security
|
62
|
115
|
76
|
Other creditors
|
29
|
26
|
44
|
Accruals and deferred income
|
246
|
554
|
233
|
Right of use liabilities
|
688
|
769
|
83
|
|
1,408
|
1,675
|
642
|
|
|
|
|
Current
|
725
|
986
|
642
|
Non-current
|
683
|
689
|
727
|
|
1,408
|
1,675
|
1,369
|
6. Loss per
share
Basic loss per share is calculated by dividing
the loss attributable to equity holders by the weighted average
number of shares in issue during the period. The Group was
loss-making for the 6-month periods ended 30 June 2024 and 30 June
2023 and also for the year ended 31 December 2023. Therefore,
the dilutive effect of share options has not been taken account of
in the calculation of diluted earnings per share, since this would
decrease the loss per share reported for each of the periods
reported.
The calculation of basic and diluted loss per
ordinary share is based on the loss for the period, as set out
below. Calculations of loss per share are calculated to two decimal
places.
|
Unaudited
|
Unaudited
|
|
|
6 months to
|
6 months
to
|
Year ended
|
|
30 June
|
30 June
|
31
December
|
|
2024
|
2023
|
2023
|
|
£'00
|
£'000
|
£'000
|
Total loss attributable to the equity holders
of the parent
|
(2,546)
|
(2,726)
|
(4,255)
|
|
Unaudited
|
Unaudited
|
|
|
6 months to
|
6 months
to
|
Year ended
|
|
30 June
|
30 June
|
31
December
|
|
2024
|
2023
|
2023
|
|
£'000
|
£'000
|
£'000
|
Issued ordinary shares at the start of the
period
|
150,982,917
|
150,982,535
|
150,980,123
|
Effect of shares issued for cash
|
160,853,651
|
2,412
|
2,605
|
Weighted average number of shares at the end of
the period
|
311,836,568
|
150,984,947
|
150,982,728
|
|
Unaudited
|
Unaudited
|
|
|
6 months to
|
6 months
to
|
Year ended
|
|
30 June
|
30 June
|
31
December
|
|
2024
|
2023
|
2023
|
Basic and diluted on loss for the
period
|
(0.82)p
|
(1.81)p
|
(2.82)p
|
7.
Leases
The Group has leases for office buildings and
associated warehousing and operational space. With the exception of
short-term leases and leases of low-value underlying assets, each
lease is reflected on the statement of financial position as a
right-of-use asset and a lease liability. The Group classifies its
right-of-use-assets in a manner consistent with its property, plant
and equipment.
Each lease generally imposes and restriction
that, unless there is a contractual right for the Group to sublet
the asset to another party, the right-of-use-asset can only be used
by the Group. Leases are either non-cancellable or may only be
cancelled by incurring a substantive termination fee. The Group is
prohibited from selling of pledging the underlying leased assets as
security. For leases over office buildings and warehousing and
operations space, the Group must keep those properties in a good
state of repair and return the properties in their original
condition at the end of the lease. Further, the Group must insure
items of property, plant and equipment and incur maintenance fees
on such items in accordance with the lease contracts.
The table below describes the nature of the
Group's leasing activities by type of right-of-use asset recognised
on the statement of financial position:
|
No. of right-of-use assets
leased
|
Remaining range
of term
|
Average remaining
lease term
|
No. of leases with termination
options
|
Land and buildings
|
2
|
46 - 93
|
70 months
|
2
|
Right-of-use
assets
Additional information on the right-of-use
assets by class is as follows:
|
Land and buildings
£'000
|
Balance as at 31 December 2022
|
718
|
Additions in the period
|
154
|
Depreciation charged in the period
|
(64)
|
Balance as at
30 June 2023
|
808
|
Depreciation charged in the period
|
(34)
|
Balance as at
31 December 2023
|
772
|
Depreciation charged in the period
|
(54)
|
Balance as at
30 June 2024
|
718
|
Lease
liabilities
Lease liabilities are presented in the
statement of financial position as follows:
|
Unaudited
|
Unaudited
|
|
|
30 June
|
30 June
|
31
December
|
|
2024
|
2023
|
2023
|
|
£'000
|
£'000
|
£'000
|
Current
|
86
|
80
|
83
|
Non-current
|
602
|
689
|
647
|
|
688
|
769
|
730
|
8.
Seasonality
The Group experiences no material variations
due to seasonality.
9.
Availability of interim statement
This interim statement will be available on
Xeros' website at www.xerostech.com
Forward-looking
statements
This announcement may include certain
forward-looking statements, beliefs or opinions, including
statements with respect to Xeros' business, financial condition and
results of operations. These forward-looking statements can
be identified by the use of forward-looking terminology, including
the terms "believes", "estimates", "plans", "anticipates",
"targets", "aims", "continues", "expects", "intends", "hopes",
"may", "will", "would", "could" or "should" or, in each case, their
negative or other various or comparable terminology. These
statements are made by the Xeros Directors in good faith based on
the information available to them at the date of this announcement
and reflect the Xeros Directors' beliefs and expectations. By their
nature these statements involve risk and uncertainty because they
relate to events and depend on circumstances that may or may not
occur in the future. A number of factors could cause actual results
and developments to differ materially from those expressed or
implied by the forward-looking statements, including, without
limitation, developments in the global economy, changes in
government policies, spending and procurement methodologies, and
failure in health, safety or environmental policies.
No representation or warranty is made that any
of these statements or forecasts will come to pass or that any
forecast results will be achieved. Forward-looking statements speak
only as at the date of this announcement and Xeros and its advisers
expressly disclaim any obligations or undertaking to release any
update of, or revisions to, any forward-looking statements in this
announcement. No statement in the announcement is intended to be,
or intended to be construed as, a profit forecast or to be
interpreted to mean that earnings per Xeros share for the current
or future financial years will necessarily match or exceed the
historical earnings. As a result, you are cautioned not to place
any undue reliance on such forward-looking statements.